Portal Instruments, a leader in patient-centric drug delivery innovation, is pleased to announce the publication of a collaborative study in the journal Bioengineering & Translational Medicine, highlighting the viability of its next-generation, needle-free injector (NFI) fo
Cambridge, MA - 26 August, 2025 – Portal Instruments Demonstrates Feasibility of Needle-Free Injection for High-Viscosity, High-Volume Biologics
Portal Instruments, a leader in patient-centric drug delivery innovation, is pleased to announce the publication of a collaborative study in the journal Bioengineering & Translational Medicine (DOI: 10.1002/btm2.70063), highlighting the viability of its next-generation, needle-free injector (NFI) for subcutaneous administration of high-viscosity monoclonal antibody (mAb) formulations.
Study Highlights
About Portal Instruments
Portal Instruments is transforming biologic drug delivery with its re-usable, electro-mechanical PRIME platform. Through rapid, precise, and comfortable delivery of high-viscosity biologics—at home or in clinical settings—the technology offers advantages in patient compliance, safety, and environment.
This study marks a major milestone in Portal’s mission to bridge the gap between intravenous and subcutaneous biologic therapies while prioritizing patient experience and advancing home administration capabilities.
December 2019 - Jay Sparks, host of Finding Unique Value podcast, chats with Dr. Anquetil about how he has leveraged his unique science and business background to create value and solve an unmet need with potential to help millions of people.
March 2024 - Portal Instruments is pleased to be returning to Dana Point, California to share its drug delivery technology with investors and other emerging medtech companies at LSI USA '24. Patrick Anquetil, CEO, will be presenting the updates.
February 11, 2020 - Gerresheimer recently published an article describing Portal Instrument’s innovative primary drug container which is used in Portal’s needle-free drug delivery platform. Read the full pdf article here.
Please fill out the details below and we will get back to you shortly.